AMWL Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
American Well Corp (AMWL) is not a strong buy for a beginner, long-term investor at this time. The company is facing significant revenue and income declines, and analysts have lowered price targets, reflecting concerns about its financial health and strategic restructuring. While technical indicators show some neutral-to-positive trends, there are no strong positive catalysts or trading signals to justify immediate investment.
The MACD is slightly positive and expanding, indicating mild bullish momentum. RSI is neutral at 60.329, and moving averages are converging, suggesting indecision. The stock is trading near its pivot level of 5.414, with resistance at 5.758 and support at 5.071. Overall, the technical indicators do not provide a strong buy signal.
NULL identified. No recent news or strong trading signals. The reaffirmation of EBITDA guidance for 2026 is a minor positive, but overshadowed by revenue decline concerns.
Analysts have lowered price targets and expressed concerns about the company's strategic restructuring and revenue guidance. No recent insider or hedge fund activity to indicate confidence in the stock.
In Q4 2025, revenue dropped to $55.31M (-22.11% YoY), net income fell to -$24.92M (-41.57% YoY), and EPS declined to -1.52 (-45.13% YoY). Gross margin also decreased to 36.06% (-2.96% YoY), reflecting deteriorating financial health.
Analysts have lowered price targets across the board: Stifel reduced to $5 from $6, TD Cowen reduced to $5 from $7, and Morgan Stanley reduced to $6 from $10.50. The consensus rating is Hold, with concerns about revenue decline and strategic restructuring overshadowing any positive EBITDA guidance.
